Link & Learn

Summary

This column is intended to stimulate discussion on the pages of LINKS and to share short formulated ideas and observations. Open is the keyword here: open to any subject; write with an open mind and an open heart; favour question marks over exclamation marks and be open to discussion. In a recent publication of a systematic review, homeopathy – besides not having benefits – is charged with causing harm. But “there is no evil without any positive outcome” (Spanish proverb), and the debate on adverse effects might illuminate the theme of primary effects, secondary effects and initial reactions of (not only!) homeopathic remedies. The work of M. Z. Teixeira – which makes adverse and rebound effects of conventional medicines available for homeopathy – will help me to disentangle this spiny subject.

Key words

Adverse effects - Primary effects - Secondary effects - Rebound effects - Initial reactions - M. Z. Teixeira

• References

• 1 Barquero Romero J, Redondo López JM, Galeano Díaz F, Pérez Miranda M. Pancreatitis aguda fatal en un paciente en tratamiento homeopático. Med Clin (Barc) 2004; 122: 318-319
• 2 Duboeuf T, De Widerspach-Thor A, Scotto B, Bacq Y. Pancréatite aiguë liée au glimépiride (Amarel®). Gastroenterol Clin Biol 2004; 28: 409-410
• 3 Posadzki P, Alotaibi A, Ernst E. Adverse effects of homeopathy: a systematic review of published case reports and case series. Int J Clin Pract 2012; 66: 1178-1188
• 4 Geukens A. Two more case histories. AJHM 2001; 94: 93-105
• 5 Knezewich E, Crnic T, Kershaw S, Drincic A. Liraglutide-associated acute pancreatitis. Am J Health Syst Pharm 2012; 69: 386-389
• 6 Hahnemann S. Organon original – Organon der Heilkunst. 6.. Auflage (facsimile). (Original work published 1921). Berg am Starnberger See: O-Verlag; 1985
• 7 Nauck M, Frid A, Hermansen K, Shah NS et al. Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (Liraglutide Effect and Action in Diabetes)-2 study. Diabetes Care 2009; 32: 84-90
• 8 Novartis Pharmaceuticals Corporation. Tegretol® (2009). Retrieved from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/016608s101,018281s048lbl.pdf [accessed December 13, 2012]
• 9 Stub T, Alræk T, Salamonsen A. The Red flag! Risk assessment among medical homeopaths in Norway: a qualitative study. BMC Complement Altern Med 2012; 12: 150 http://www.biomedcentral.com/1472-6882/12/150 Retrieved from:
• 10 Teixeira MZ. New Homeopathic Medicines. Online: http://www.novosmedicamentoshomeopaticos.com/eng/presentation.asp [accessed July 12, 2013]
• 11 Teixeira MZ. NSAIDs, myocardial infarction, rebound effect and similitude. Homeopathy 2007; 96: 67-68
• 12 Teixeira MZ. Bronchodilators, fatal asthma, rebound effect and similitude. Homeopathy 2007; 96: 135-137
• 13 Teixeira MZ. Antidepressants, suicidality and rebound effect: evidence of similitude?. Homeopathy 2009; 98: 114-121
• 14 Teixeira MZ. Statins withdrawal, vascular complications, rebound effect and similitude. Homeopathy 2010; 99: 255-262
• 15 Teixeira MZ. Rebound acid hypersecretion after withdrawal of gastric acid suppressing drugs: new evidence of similitude. Homeopathy 2011; 100: 148-156
• 16 Teixeira MZ. Antiresorptive drugs (bisphosphonates), atypical fractures and rebound effect: new evidence of similitude. Homeopathy 2012; 101: 231-242